Akeso, Inc. (AKESF)
12.10
-0.10
(-0.82%)
USD |
OTCM |
Jun 09, 16:00
Akeso 1 Year Total Returns (Daily) : 7.89% for June 9, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 09, 2026 | 7.89% |
| June 08, 2026 | 16.19% |
| June 05, 2026 | 15.24% |
| June 04, 2026 | 25.66% |
| June 03, 2026 | 35.89% |
| June 02, 2026 | 49.48% |
| June 01, 2026 | 43.91% |
| May 29, 2026 | 37.45% |
| May 28, 2026 | 31.36% |
| May 27, 2026 | 36.04% |
| May 26, 2026 | 35.26% |
| May 22, 2026 | 36.61% |
| May 21, 2026 | 47.23% |
| May 20, 2026 | 38.36% |
| May 19, 2026 | 35.64% |
| May 18, 2026 | 37.38% |
| May 15, 2026 | 52.38% |
| May 14, 2026 | 50.94% |
| May 13, 2026 | 58.96% |
| May 12, 2026 | 66.43% |
| May 11, 2026 | 59.68% |
| May 08, 2026 | 57.53% |
| May 07, 2026 | 55.41% |
| May 06, 2026 | 46.52% |
| May 05, 2026 | 40.72% |
| Date | Value |
|---|---|
| May 04, 2026 | 44.83% |
| May 01, 2026 | 52.43% |
| April 30, 2026 | 54.18% |
| April 29, 2026 | 54.87% |
| April 28, 2026 | 50.64% |
| April 27, 2026 | 25.09% |
| April 24, 2026 | 28.79% |
| April 23, 2026 | 31.78% |
| April 22, 2026 | 69.37% |
| April 21, 2026 | 80.12% |
| April 20, 2026 | 80.12% |
| April 17, 2026 | 80.12% |
| April 16, 2026 | 70.60% |
| April 15, 2026 | 55.19% |
| April 14, 2026 | 55.23% |
| April 13, 2026 | 66.53% |
| April 10, 2026 | 89.03% |
| April 09, 2026 | 84.72% |
| April 08, 2026 | 95.03% |
| April 07, 2026 | 105.4% |
| April 06, 2026 | 64.85% |
| April 02, 2026 | 62.07% |
| April 01, 2026 | 71.15% |
| March 31, 2026 | 70.27% |
| March 30, 2026 | 85.56% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Ascletis Pharma, Inc. | 44.77% |
| CStone Pharmaceuticals Co. Ltd. | 34.14% |
| RemeGen Co., Ltd. | 87.75% |
| InnoCare Pharma Ltd. | -52.45% |
| Adagene, Inc. | 78.01% |